[{"data":1,"prerenderedAt":65},["ShallowReactive",2],{"q-nurse-107-2-basic-medicine-036":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":34,"lastmod":64},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"explanationDeep":23,"topics":24,"freq":11},"nurse-107-2-基礎醫學-036","nurse-107-2-basic-medicine-036",107,2,36,"慢性骨髓性白血病與下列那一個基因有關？",{"A":15,"B":16,"C":17,"D":18},"RAS","MYC","ABL","NF-1","C",null,[],"本題考點是慢性骨髓性白血病的分子標記。依腫瘤遺傳學,慢性骨髓性白血病（CML）的標誌是費城染色體——第 9 與 22 號染色體易位 t(9;22),使 22 號的 BCR 與 9 號的 ABL 融合成 BCR-ABL 基因,產生持續活化的酪胺酸激酶,故與 ABL 有關,選 C。A RAS 是多種實體癌常見的致癌基因點突變,非 CML 標記。B MYC 與 Burkitt 淋巴瘤 t(8;14) 相關。D NF-1 是神經纖維瘤病第一型的腫瘤抑制基因,與 CML 無關。","機轉:BCR-ABL 融合蛋白具不受控的酪胺酸激酶活性,驅動骨髓細胞增生,這正是標靶藥 imatinib（基利克）抑制的對象,是分子標靶治療的經典成功案例。記憶連結:費城染色體＝Philadelphia＝t(9;22)＝BCR-ABL＝CML＝imatinib。易混對比:MYC↔Burkitt t(8;14);BCL-2↔濾泡型淋巴瘤 t(14;18);PML-RARα↔急性前骨髓性白血病 t(15;17)＝ATRA 治療。可連結:酪胺酸激酶抑制劑、微量殘存疾病監測。",[25,27,29,32],{"term":26,"count":11},"費城染色體 t(9;22)",{"term":28,"count":11},"BCR-ABL 融合基因",{"term":30,"count":31},"慢性骨髓性白血病 CML",1,{"term":33,"count":31},"ABL 酪胺酸激酶",[35,39,44,48,53,58],{"webId":36,"stem":37,"number":38,"year":10,"session":11},"nurse-107-2-basic-medicine-037","關於異生（dysplasia）的敘述，下列何者正確？",37,{"webId":40,"stem":41,"number":42,"year":43,"session":31},"nurse-108-1-basic-medicine-053","下列何者不是治療骨質疏鬆症的藥物？",53,108,{"webId":45,"stem":46,"number":47,"year":43,"session":11},"nurse-108-2-basic-medicine-067","預防白喉可注射何種疫苗？",67,{"webId":49,"stem":50,"number":51,"year":52,"session":31},"nurse-110-1-basic-medicine-025","下列那一種神經膠細胞（neuroglia cells）可幫助調節腦脊髓液（cerebrospinal fluid）的生成與流動？",25,110,{"webId":54,"stem":55,"number":56,"year":57,"session":31},"nurse-111-1-basic-medicine-069","絕對厭氧菌不能在有氧環境下生長，是因為缺乏以下何種酵素？",69,111,{"webId":59,"stem":60,"number":61,"year":62,"session":63},"nurse-112-3-basic-medicine-033","下列何種藥物最適合給與初診斷為第二型糖尿病且尚無併發症之病人？",33,112,3,"2026-09-04",1788510723604]